report banner

News in English

PostNews: Press Release
The HoloMonitor live cell imaging system inside a BioSpherix Xvivo incubator investor relations

BioSpherix Partnership Yields HoloMonitor Customer in Regenerative Medicine

Recently, the EU-funded Centre for Innovative Medicine in Vilnius purchased its first HoloMonitor analyzer for use in the center’s incubator system from BioSpherix.
Learn more …
PostNews: Press Release
Massachusetts Eye and Ear Infirmary building

Harvard Researchers Purchase HoloMonitor

Partners HealthCare International in Boston, Massachusetts, recently ordered its first and fully equipped HoloMonitor unit.
Learn more …
PostNews: Interim Report
Closeup of HoloMonitor's objective

Interim Report 3 (2020-11-01 – 2021-01-31)

The second wave of the pandemic restricted sales during the 3rd quarter. However, the situation has improved significantly since late January.
Learn more …
PostNews: Press Release
The Oresund Bridge

PHI Secure Working Capital Until 2023

PHI has received a second loan commitment of 20 MSEK. In total, the company has received loan commitments of 35 MSEK that are expected to secure the company’s working capital until 2023.
Learn more …
PostNews: Interim Report
3D cells on a blue background imaged by the HoloMonitor live cell imager.

Interim Report 2 (2020-08-01 – 2020-10-31)

The relaxed COVID-19 restrictions during the 2nd quarter led to a noticeable increase in sales.
Learn more …
PostNews: Interim Report
The new default way of meeting customers — an online seminar, explaining the benefits of HoloMonitor.

Interim Report 1 (2020-05-01 – 2020-07-31)

The global COVID-19 restrictions have dramatically affected customers’ ability to receive us for onsite demonstrations, installations and customer training. Despite this, several HoloMonitor units have been delivered since the beginning of the fiscal year in May.
Learn more …
1131415161733